Hope for long COVID sufferers: new drug trial targets debilitating fatigue
NCT ID NCT06128967
First seen May 04, 2026 · Last updated May 06, 2026 · Updated 1 time
Summary
This study tested an experimental medication to see if it could reduce fatigue and other symptoms in adults with long COVID. About 400 participants who had persistent symptoms for over 12 weeks after a COVID-19 infection took either the drug or a placebo. The goal was to improve daily functioning and reduce hospitalizations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC FATIGUE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CARDRESEARCH - Cardiologia Assistencial e de Pesquisa
Belo Horizonte, Minas Gerais, 30150240, Brazil
-
City of Brumadinho
Brumadinho, Minas Gerais, 35.460-000, Brazil
-
City of Ibirité Public Health Authority
Ibirité, Minas Gerais, Brazil
-
Governador Valadares City Public Health Authority
Governador Valadares, Minas Gerais, Brazil
-
Sociedade Padrao de Educacao Superior
Montes Claros, Minas Gerais, Brazil
-
Universidade Federal de Ouro Preto
Ouro Preto, Minas Gerais, 35400000, Brazil
Conditions
Explore the condition pages connected to this study.